Advertisement

Mosunetuzumab for Relapsed or Refractory Aggressive and Indolent B-Cell Non-Hodgkin Lymphomas
Posted: 02/10/2022 | By: Matthew Stenger

Question 1 of 5

What kind of agent is mosunetuzumab?

Choose 1

A
A third-generation CD38-directed antibody
B
A bispecific antibody targeting CD20 and CD3 on B cells
C
A bispecific antibody targeting CD20 on B cells and CD3 on T cells
D
None of the above

CategoriesView All Quizzes

Tumor Type


Additional Topics



Conference Coverage